10.17.13
Alpharetta, Ga.-based Sanuwave Health Inc. has been awarded a patent from the U.S. Patent and Trademark Office titled “Extracorporeal Shock Wave Device.” The claims of the patent relate to a new extracorporeal applicator, and the patent has a term extending to April 2031.
“This new type of applicator can be used for cardiology, endovascular, as well as other applications,” said Joseph Chiarelli, CEO of Sanuwave. “Our strategy is to maximize the value of Sanuwave’s shock wave technology—to expand the technology’s use into as many applications as possible via this new applicator design.”
The patent protects a special reflector geometry that the company intends to incorporate into future applicators. The applicator design has its reflector opening intersecting the focal line of an ellipse at a non-perpendicular angle, whereas the existing applicators use classic reflectors that intersect the focal line of an ellipse only at a perpendicular angle. According to Sanuwave, this provides significant advantages compared with existing invasive surgical procedures in that it aids in the elimination of cardiovascular occlusions and atherosclerosis, regardless of vessel dimension.
Sanuwave is a shock wave technology company initially focused on making noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.
“This new type of applicator can be used for cardiology, endovascular, as well as other applications,” said Joseph Chiarelli, CEO of Sanuwave. “Our strategy is to maximize the value of Sanuwave’s shock wave technology—to expand the technology’s use into as many applications as possible via this new applicator design.”
The patent protects a special reflector geometry that the company intends to incorporate into future applicators. The applicator design has its reflector opening intersecting the focal line of an ellipse at a non-perpendicular angle, whereas the existing applicators use classic reflectors that intersect the focal line of an ellipse only at a perpendicular angle. According to Sanuwave, this provides significant advantages compared with existing invasive surgical procedures in that it aids in the elimination of cardiovascular occlusions and atherosclerosis, regardless of vessel dimension.
Sanuwave is a shock wave technology company initially focused on making noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.